Castle Biosciences (CSTL) Net Cash Flow Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 41.14% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 29.81% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 4.49% |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | -86.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.79% |
| Dec 31, 2025 | 68.40% |
| Sep 30, 2025 | 26.49% |
| Jun 30, 2025 | 40.75% |
| Mar 31, 2025 | -13.34% |
| Dec 31, 2024 | 39.90% |
| Sep 30, 2024 | 56.30% |
| Jun 30, 2024 | 27.40% |
| Mar 31, 2024 | -76.89% |
| Dec 31, 2023 | -67.74% |
| Sep 30, 2023 | -50.56% |
| Jun 30, 2023 | -30.72% |
| Mar 31, 2023 | -248.51% |
| Dec 31, 2022 | -65.95% |
| Sep 30, 2022 | -56.12% |
| Jun 30, 2022 | -214.00% |
| Mar 31, 2022 | -55.42% |
| Dec 31, 2021 | -210.34% |
| Sep 30, 2021 | -38.83% |